JAK inhibitors for the treatment of autoimmune and inflammatory diseases

Y Jamilloux, T El Jammal, L Vuitton… - Autoimmunity …, 2019 - Elsevier
Cytokines play a central role in the pathophysiology of autoimmune and inflammatory
diseases. Several cytokines signal through the JAK-STAT pathway, which is now recognized …

[HTML][HTML] JAK inhibitors and autoimmune rheumatic diseases

M Benucci, P Bernardini, C Coccia, R De Luca… - Autoimmunity …, 2023 - Elsevier
The four Janus kinase (JAK) proteins and the seven Signal Transducers of Activated
Transcription (STAT) mediate intracellular signal transduction downstream of cytokine …

Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

DM Schwartz, M Bonelli, M Gadina… - Nature Reviews …, 2016 - nature.com
Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have
revolutionized the treatment of immune-mediated diseases. Despite the effectiveness of …

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?

E Favoino, M Prete, G Catacchio, P Ruscitti… - Autoimmunity …, 2021 - Elsevier
The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is
an important intracellular route through which many different extracellular soluble …

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis

GE Fragoulis, IB McInnes, S Siebert - Rheumatology, 2019 - academic.oup.com
Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of
molecules associated with one of the major pathways through which many cytokines exert …

JAK inhibitors for the treatment of rheumatoid arthritis

A Morinobu - Immunological medicine, 2020 - Taylor & Francis
The treatment of rheumatoid arthritis has changed dramatically over the last two decades
since the development of biological disease-modifying anti-rheumatic drugs (bDMARDs) …

Janus kinase inhibitors in autoimmune diseases

JJ O'Shea, A Kontzias, K Yamaoka, Y Tanaka… - Annals of the …, 2013 - ard.bmj.com
Biological therapies directed at proinflammatory cytokines have irrevocably changed the
landscape of treatment of rheumatoid arthritis (RA) and other autoimmune diseases. With …

[HTML][HTML] JAK/STAT pathway in pathology of rheumatoid arthritis

DA Ciobanu, IS Poenariu… - Experimental and …, 2020 - spandidos-publications.com
Rheumatoid arthritis (RA) is classified as an inflammatory, chronic autoimmune and
disabling disease based on the intricate interplay between environmental and genetic …

A decade of JAK inhibitors: what have we learned and what may be the future?

C Liu, J Kieltyka, R Fleischmann… - Arthritis & …, 2021 - Wiley Online Library
The discovery of cytokines and their role in immune and inflammatory disease led to the
development of a plethora of targeted biologic therapies. Later, efforts to understand …

Selective Janus kinase inhibitors come of age

JJ O'Shea, M Gadina - Nature Reviews Rheumatology, 2019 - nature.com
Janus kinase (JAK) inhibitors (jakinibs) that target downstream signalling by a large range of
cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that …